GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report
The Institute for Clinical and Economic Review (ICER) released a report on Monday assessing the clinical effectiveness and ...
2minutemedicine.com22h
Depemokimab therapy reduces exacerbations in patients with severe eosinophilic asthma
In this randomized, placebo-controlled replicate trial, depemokimab decreased the annual rate of exacerbations among patients ...